Cytel Opens Solara to General Release & Launches New Trial Optimization Solution for Biotechs

Published on: 

Cytel announces that its clinical trial design and statistical software solution Solara is now available for general release to the pharma industry. Solara is available in two formats: standalone SaaS product, and as part of a consultancy solution. The consultancy solution is directed to smaller biopharma companies, which may lack an in-house biostatistician to lead the clinical trial design process.

For more information, click here.